JP2024525566A5 - - Google Patents
Info
- Publication number
- JP2024525566A5 JP2024525566A5 JP2024500249A JP2024500249A JP2024525566A5 JP 2024525566 A5 JP2024525566 A5 JP 2024525566A5 JP 2024500249 A JP2024500249 A JP 2024500249A JP 2024500249 A JP2024500249 A JP 2024500249A JP 2024525566 A5 JP2024525566 A5 JP 2024525566A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163220006P | 2021-07-09 | 2021-07-09 | |
| US63/220,006 | 2021-07-09 | ||
| PCT/US2022/034493 WO2023283049A1 (en) | 2021-07-09 | 2022-06-22 | Pharmaceutical compositions of a pd-1 antibody and use of the same |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024525566A JP2024525566A (ja) | 2024-07-12 |
| JP2024525566A5 true JP2024525566A5 (https=) | 2025-06-30 |
| JPWO2023283049A5 JPWO2023283049A5 (https=) | 2025-06-30 |
Family
ID=82608118
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024500249A Pending JP2024525566A (ja) | 2021-07-09 | 2022-06-22 | Ｐｄ‐１抗体の医薬組成物及びその使用 |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US12364756B2 (https=) |
| EP (1) | EP4366692A1 (https=) |
| JP (1) | JP2024525566A (https=) |
| KR (1) | KR20240035533A (https=) |
| CN (1) | CN118215465A (https=) |
| AR (1) | AR126404A1 (https=) |
| AU (1) | AU2022307332A1 (https=) |
| CA (1) | CA3224640A1 (https=) |
| CL (1) | CL2024000077A1 (https=) |
| CO (1) | CO2024000198A2 (https=) |
| CR (1) | CR20240065A (https=) |
| EC (1) | ECSP24008791A (https=) |
| IL (1) | IL309985A (https=) |
| MX (1) | MX2024000268A (https=) |
| PE (1) | PE20240797A1 (https=) |
| TW (1) | TW202308694A (https=) |
| WO (1) | WO2023283049A1 (https=) |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT1946776T (pt) * | 2002-02-27 | 2017-03-17 | Immunex Corp | Composição de tnfr-fc estabilizada compreendendo arginina |
| WO2017019846A1 (en) * | 2015-07-30 | 2017-02-02 | Macrogenics, Inc. | Pd-1-binding molecules and methods use thereof |
| JOP20190260A1 (ar) * | 2017-05-02 | 2019-10-31 | Merck Sharp & Dohme | صيغ ثابتة لأجسام مضادة لمستقبل الموت المبرمج 1 (pd-1) وطرق استخدامها |
| US12150990B2 (en) * | 2017-11-02 | 2024-11-26 | Nanjing Shunxin Pharmaceutical Co., Ltd. | Pharmaceutical composition of humanized monoclonal anti-PD-L1 antibody |
| IL277095B2 (en) * | 2018-03-07 | 2025-10-01 | Pfizer | Preparations containing anti-PD-1 antibody |
| CN110404066B (zh) * | 2018-04-28 | 2022-06-17 | 齐鲁制药有限公司 | 一种抗人pd-1的单克隆抗体制剂、联合用药物及其用途 |
| EP4007602A1 (en) * | 2019-08-01 | 2022-06-08 | Incyte Corporation | A dosing regimen for an ido inhibitor |
| PH12022550244A1 (en) * | 2019-08-05 | 2022-12-12 | Nat Cancer Ct | Biomarkers for determining the efficacy of immune checkpoint inhibitors |
-
2022
- 2022-06-22 US US17/847,094 patent/US12364756B2/en active Active
- 2022-06-22 EP EP22744039.3A patent/EP4366692A1/en active Pending
- 2022-06-22 CA CA3224640A patent/CA3224640A1/en active Pending
- 2022-06-22 AU AU2022307332A patent/AU2022307332A1/en active Pending
- 2022-06-22 IL IL309985A patent/IL309985A/en unknown
- 2022-06-22 MX MX2024000268A patent/MX2024000268A/es unknown
- 2022-06-22 KR KR1020247004643A patent/KR20240035533A/ko active Pending
- 2022-06-22 JP JP2024500249A patent/JP2024525566A/ja active Pending
- 2022-06-22 CR CR20240065A patent/CR20240065A/es unknown
- 2022-06-22 PE PE2024000052A patent/PE20240797A1/es unknown
- 2022-06-22 WO PCT/US2022/034493 patent/WO2023283049A1/en not_active Ceased
- 2022-06-22 CN CN202280059325.XA patent/CN118215465A/zh active Pending
- 2022-07-05 TW TW111125067A patent/TW202308694A/zh unknown
- 2022-07-07 AR ARP220101785A patent/AR126404A1/es unknown
-
2024
- 2024-01-09 CL CL2024000077A patent/CL2024000077A1/es unknown
- 2024-01-11 CO CONC2024/0000198A patent/CO2024000198A2/es unknown
- 2024-02-02 EC ECSENADI20248791A patent/ECSP24008791A/es unknown
-
2025
- 2025-07-21 US US19/275,898 patent/US20250345422A1/en active Pending